Following OTC Valuations’ (OTC Val) acquisition by Tullett Prebon earlier this year, OTC Val has been selected by leading hedge fund CQS, to provide monthly independent valuation reports for their complex structured credit portfolio.
Shaun Brick, head of product control at CQS, commented: “As part of CQS’s continuing process of enhancing control and pricing accuracy of bespoke credit positions several valuation providers were evaluated for suitability, with OTC Val selected as a preferred supplier. Our primary selection factors were based around complex product valuation capabilities, model calibration expertise, and demonstrable client services and support. OTC Val’s transparent valuation process demonstrates their capabilities go beyond delivering a price.”
Miroslav Vanous, head of EMEA at OTC Val, said: “Following a detailed evaluation process, we are pleased to have been selected from a shortlist of leading service providers to deliver independent valuation reports to CQS. As a proven provider of independent valuations of OTC derivatives, structured products, and illiquid securities, OTC Val is often utilized as a primary pricing source or as a verification of existing counterparty and broker quotes. We therefore believe that clients such as CQS remain ahead of their peer group in using truly independent and auditable valuations for the purposes of compliance, positive investor perception, and risk management review.”